Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Cirrhosis, Liver

1-methyl-3-isobutylxanthine has been researched along with Cirrhosis, Liver in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"We have combined an ex vivo model of liver fibrosis with measurement of a biochemical marker of collagen degradation in the condition medium."1.38Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model. ( Karsdal, MA; Leeming, DJ; Nielsen, MJ; Veidal, SS, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Veidal, SS1
Nielsen, MJ1
Leeming, DJ1
Karsdal, MA1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Cirrhosis, Liver

ArticleYear
Phosphodiesterase inhibition mediates matrix metalloproteinase activity and the level of collagen degradation fragments in a liver fibrosis ex vivo rat model.
    BMC research notes, 2012, Dec-18, Volume: 5, Issue:1

    Topics: 1-Methyl-3-isobutylxanthine; Animals; Cell Survival; Collagen Type III; Cyclic AMP; Electrophoresis,

2012